Circular RNA circAGO2 drives cancer progression through facilitating HuR-repressed functions of AGO2-miRNA complexes

Yajun Chen1, Feng Yang2, Erhu Fang2

  • 1Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, 430022, Wuhan, Hubei Province, China.

Insights

A novel circular RNA (circRNA) called circAGO2 promotes cancer by interfering with Argonaute 2 (AGO2) and microRNA (miRNA) silencing. Targeting circAGO2 or its interaction with HuR protein inhibits tumor growth and spread.

Area of Science:

  • Molecular Biology
  • Oncology
  • RNA Biology

Background:

  • Argonaute 2 (AGO2) is crucial for microRNA (miRNA)-mediated gene silencing and implicated in cancer.
  • The regulatory mechanisms governing AGO2 function in cancer remain incompletely understood.
  • Circular RNAs (circRNAs) are emerging as significant players in various biological processes, including cancer.

Purpose of the Study:

  • To identify and characterize novel regulators of AGO2 function in cancer.
  • To investigate the role of circRNAs in modulating AGO2-miRNA complexes.
  • To explore circAGO2 as a potential therapeutic target for cancer treatment.

Main Methods:

  • Identification and characterization of circAGO2 derived from the AGO2 gene.
  • Expression analysis of circAGO2 in various cancer types (gastric, colon, prostate, neuroblastoma).
  • In vitro and in vivo assays to assess the functional role of circAGO2 in cancer cell growth, invasion, and metastasis.
  • Mechanistic studies involving RNA-protein interaction assays (e.g., RIP-qPCR) to investigate the interaction between circAGO2 and HuR.
  • Therapeutic interventions using shRNA targeting circAGO2 and cell-penetrating peptides to block circAGO2-HuR interaction in preclinical models.

Main Results:

  • CircAGO2 is significantly upregulated in multiple cancers and correlates with poor patient prognosis.
  • CircAGO2 promotes cancer cell proliferation, invasion, and metastasis both in vitro and in vivo.
  • CircAGO2 interacts with HuR protein, enhancing its activity and leading to reduced AGO2 binding and impaired miRNA-mediated gene silencing.
  • Targeting circAGO2 with shRNA or blocking its interaction with HuR using peptides effectively suppresses tumor growth and aggressiveness in preclinical models.

Conclusions:

  • Oncogenic circAGO2 acts as a novel regulator of AGO2-miRNA complexes in cancer progression.
  • CircAGO2 drives tumorigenesis and metastasis by facilitating HuR-mediated repression of AGO2/miRNA silencing.
  • CircAGO2 and its interaction with HuR represent promising therapeutic targets for inhibiting cancer growth and spread.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.8K
Facilitated Transport01:19

Facilitated Transport

The chemical and physical properties of plasma membranes cause them to be selectively permeable. Since plasma membranes have both hydrophobic and hydrophilic regions, substances need to be able to transverse both regions. The hydrophobic area of membranes repels substances such as charged ions. Therefore, such substances need special membrane proteins to cross a membrane successfully. In  facilitated transport, also known as facilitated diffusion, molecules and ions travel across a...
148.1K
Facilitated Transport01:19

Facilitated Transport

The chemical and physical properties of plasma membranes cause them to be selectively permeable. Since plasma membranes have both hydrophobic and hydrophilic regions, substances need to be able to transverse both regions. The hydrophobic area of membranes repels substances such as charged ions. Therefore, such substances need special membrane proteins to cross a membrane successfully. In  facilitated transport, also known as facilitated diffusion, molecules and ions travel across a...
18.7K
Repressed Memory01:16

Repressed Memory

Repressed memories are a psychological phenomenon where memories of traumatic events are unconsciously blocked from a person's awareness. This process occurs as a defense mechanism, protecting the mind from the emotional impact of distressing or painful experiences. For example, a person who has experienced childhood trauma may grow up with no conscious recollection of the event. In such cases, the memories are thought to be buried deep within the subconscious, inaccessible to the conscious...
519
Social Facilitation01:04

Social Facilitation

Not all intergroup interactions lead to negative outcomes. Sometimes, being in a group situation can improve performance. Social facilitation occurs when an individual performs better when an audience is watching than when the individual performs the behavior alone. This typically occurs when people are performing a task for which they are skilled.
36.6K
Facilitated Diffusion01:16

Facilitated Diffusion

The plasma membrane, a critical structure in cellular biology, houses an array of transporters, or carrier proteins, interspersed within its lipid bilayer. These proteins play a crucial role in solute transport through facilitated diffusion, a form of passive diffusion that uses transporters to move the molecules across the membrane.
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
1.3K